Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-512-4 | CAS number: 7601-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Well conducted study performed according to OECD and EPA guidelines. The top-dose was not based on dose-limiting toxicity but on antithyroid effects, limiting the sensitivity of the study for classification for Developmental Effects classification. Justification for read-across : Perchloric acid, once absorbed in the general circulation is expected to be transformed into perchlorate moiety because of the blood buffering effect. Mammalian toxicity data of a perchlorate salt : ammonium perchlorate (CAS no. 7790-98-9), has been used for read across where data gaps for perchloric acid exist.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3700 (Prenatal Developmental Toxicity Study)
- Deviations:
- not specified
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- yes
- Remarks:
- Highest dose chosen with the aim to induce antithyroid effects, but not based on dose-limiting toxicity.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Ammonium perchlorate
- EC Number:
- 232-235-1
- EC Name:
- Ammonium perchlorate
- Cas Number:
- 7790-98-9
- Molecular formula:
- ClHO4.H3N
- IUPAC Name:
- ammonium perchlorate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Physical state: solid powder
- Nominal purity: 99.8%
- Lot/batch No.: 03907LF
- Stability under test conditions: Stability of formulations was established for up to 109 days.
- Storage condition of test material: at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories (Raleigh, NC).
- Age at study initiation: Female rats were approximately 59 days old at arrivai and only female rats were treated; untreated male rats, approximately 73 days old at arrivai, were used only as breeders.
- Weight at study initiation: no data
- Fasting period before study: no
- Housing: stainless steel wire-bottomed cages, individual except during mating
- Diet (e.g. ad libitum): PMI Certified Rodent Diet, ad libitum
- Water (e.g. ad libitum): reverse osmosis water, ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2° C
- Humidity (%): 50 ± 15%
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 2000-01-25 To: 2000-03-15
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on exposure:
- Test formulations of ammonium perchlorate in deionized water were prepared at least weekly, stored refrigerated, and dosage solutions were brought to room temperature prior to use. Stability of formulations was established for up to 109 days. Test drinking solutions were adjusted to concentrations that yielded target doses of 0 (control), 0.01, 0.1, 1 and 30 mg/kg-day based on actual weekly water consumption.
- Analytical verification of doses or concentrations:
- yes
- Details on mating procedure:
- - Impregnation procedure: cohoused with treated males
- M/F ratio per cage: 1:1
- Length of cohabitation: 9 days
- No replacement of males or further mating, as only presumably pregnant females were assigned to gestation study.
- Verification of same strain and source of both sexes: yes
- Proof of pregnancy: vaginal plug or sperm in vaginal smear; referred to as day 0 of pregnancy - Duration of treatment / exposure:
- 36 to 44 days: 14 days prior to mating, 1-9 days of mating, and 21 days of gestation before sacrifice.
- Frequency of treatment:
- Continuous (treated water ad libitum)
- Duration of test:
- Approximately 50 days
- No. of animals per sex per dose:
- 24 rats per exposure group.
Five dose groups of 24 satellite rats per exposure group were also housed in the same animal room and received the same regimen of treatment. Satellite rats were used for collection of blood and thyroid tissues to prevent interference with the fetal evaluations in the main study. - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: 10 mg/kg/day resulted in antithyroid effects in pups in a neurobehavioral study, and in adults in a 90-day study (7.5.1)
- Rationale for animal assignment: random
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily for viability
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily during pregnancy only
BODY WEIGHT: Yes
- Time schedule for examinations: twice during acclimation and daily throughout exposure period
FOOD CONSUMPTION: Yes
- Time schedule: daily throughout exposure period
WATER CONSUMPTION AND COMPOUND INTAKE: Yes
- Time schedule for examinations: weekly, individually
- Calculated as mg/kg/day from body weight data
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 21
- Organs examined: gross necropsy of all viscera.
OTHER:
Serum was aliquotted into three vials for TSH, triiodothyronine (T3), and T4 determinations and shipped (frozen on dry ice) to Air Force Research Laboratory (Wright Patterson Air Force Base, Dayton, Ohio; Meyer 1998) for determination of TSH, T3 , and T4 levels. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: placental abnormalities - Fetal examinations:
- - External examinations: Yes: all per litter
- Soft tissue examinations: Yes: half per litter
- Skeletal examinations: Yes: half per litter
- Head examinations: Yes: half per litter - Statistics:
- Clinical observation and other proportion data were analyzed using the variance test for homogeneity of the binomial distribution (Snedecor and Cochran 1967). Continuous data (e.g., maternal body weights, body weight changes, feed and water consumption values, and litter averages for percent male fetuses, percent resorbed conceptuses, fetal body weights, fetal anomaly data, fetal ossification site data, and thyroid hormone levels) were analyzed using Bartlett's test of homogeneity of variances (Sokal and Rohlf 1969) and the analysis of variance (Snedecor and Cochran 1967), when appropriate (i.e., Bartlett's test was not significant [p > .05]. If the analysis of variance was significant (p =< .05), Dunnett's test (Dunnett 1955) was used to identify the statistical significance of the individual groups.
If the analysis of variance was not appropriate (i.e., Bartlett's test was significant [p =< .05] , the Kruskal-Wallis test (Sokal and Rohlf 1969) was used, when less than or equal to 75% ties were present; and when more than 75% ties were present, Fisher's exact test (Siegel 1956) was used. In cases in which the Kruskal-Wallis Test was statistically significant (p =< .05),Dunn 's method of multiple comparisons (Dunn 1964) was used to identify the statistical significance of the individual groups. Count data obtained at cesarean-sectioning were evaluated using the procedures previously described for the Kruskal-Wallis test (Sokal and Rohlf 1969). - Indices:
- % Pre-implantation loss and % Post-implantation loss were not calculated in the report. Recalculated by RSS author as:
% Pre-implantation loss = 100 * (Number of corpora lutea - Number of implantation sites) / Number of corpora lutea
% Post-implantation loss = 100 * (Number of implantation sites - Number of live fetuses) / Number of implantation sites
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
Alopecia in 3 top-dose females, not toxicologically relevant.
Exposure to ammonium perchlorate in the drinking water up to 30 mg/kg-day had the expected effect of increasing serum TSH levels and decreasing serum T3 and T4 levels at all exposures tested based on the mechanism-of-action of perchlorate (USEPA 1998, 2002). Serum TSH levels were significantly increased (p =< .001) and serum T 4 levels were significantly decreased (p =< .001) at all exposure levels in an exposure-related manner. There was also a statistically significant decrease (p =< .01) in serum T3 levels at the 30 mg/kg-day target exposure, compared to the control carrier group values.
The absolute thyroid weights and ratios of thyroid weight to terminal body weight from the satellite dams in the 30.0 mg/kg/day exposure group were significantly increased (p =< .01) over the carrier control exposure group values. Microscopic examination of the thyroid glands for the satellite dams revealed hypertrophy (grade 1) of the follicular epithelium and decreased colloid (grades 2 to 3) in the dams in the 30.0 mg/kg-day exposure groups that was considered treatment related. Two dams in this exposure group were also observed to have thyroid hyperplasia. No treatment-related microscopie changes were observed in the thyroid gland of any dams offered 0.01, 0.1, or 1.0 mg/kg/day of ammonium perchlorate.
Effect levels (maternal animals)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 30 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Basis for effect level:
- other: developmental toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes. Remark: minimal & non adverse
Details on embryotoxic / teratogenic effects:
There appeared to be an increase in % pre- and post-implantation losses* and a decrease in number of live fetuses, but dose-relationship was unclear and the number of implantation sites was unaffected by treatment. The effects are not considered as being toxicologically relevant. NB: an absence of impact on number of pups has been confirmed in a 2-generation study in rats treated at up to 30 mg/kg/day (see 7.8.1).
*: comparison with historical control impossible since these indices were not calculated in historical data.
There are 3% and 8% fewer ossification sites in sternum and forelimb phalanges, respectively, at 30 mg/kg/day vs. controls.** This effect is minimal, and not adverse: it represents a slight delay in development which is usually reversible.
**: the control group was already outside the historical range for sternal ossification sites: historical control data inadequate for interpretation.
No teratogenic effects.
The serum levels of fetal TSH in the 1 and 30 mg/kg-day exposure groups from the satellite litters were significantly increased (p =< .01 or p =< .001), and the serum T4 level were significantly decreased (p =< .01) at the 30 mg/kg-day exposure level, and fetal T3 levels were significantly decreased (p =< .01
or p =< .001) at all exposure levels in an exposure-dependent manner.
Decreased colloid was observed since the 0.01 mg/kg/day group (3/32) to reach a 25/32 and a 32/32 incidence in the 1.0 mg/kg/day and 30 mg/kg/day respectively. However, in the 0.1 mg/kg/day group, only one female fetuses presented decreased colloid.
No follicular hypertrophy or hyperplasia was observed in the 30 mg/kg/day group. Only one male and one female featuses presented hyperplasia in the 1 mg/kg/day group.
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 30 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Developmental toxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Reproductive indices and ossification sites in rats treated with ammonium perchlorate
Dose (mg/kg/day) |
0 |
0.01 |
0.1 |
1 |
30 |
Corpora lutea |
19.3 |
17.9 |
18.1 |
19.8 |
19.8 |
Implantations |
17.0 |
14.7 |
14.4 |
16.6 |
14.8 |
Live fetuses |
16.6 |
14.3 |
13.9 |
16.2 |
14.1* |
% Pre-implantation loss @ |
11.9 |
17.9 |
20.4 |
16.2 |
25.3 |
% Post-implantation loss @ |
2.4 |
2.7 |
3.5 |
2.4 |
4.7 |
Ossification sites (per fetus per litter): |
|||||
- Sternal center |
4.00 |
3.93 |
3.97 |
3.96 |
3.88** |
- Forelimb phalanges |
6.97 |
6.78 |
6.68 |
7.01 |
6.43* |
@: no statistical analysis performed since these data were not in the original report
*: p<0.05; **: p<0.01
Applicant's summary and conclusion
- Conclusions:
- Maternal general NOAEL is 30 mg/kg/day in the absence of relevant general toxicity maternal effects. However, because of thyroid follicular cells hypertrophy/hyperplasia, maternal NOAEL is set at 1 mg/kg/day.
Developmental NOAEL set at 30 mg/kg/day in the absence of adverse developmental abnormalities and thyroid follicular cells hypertrophy/hyperplasia.
The top-dose was not based on dose-limiting toxicity but on antithyroid effects, limiting the sensitivity of the study for Developmental Effects classification. - Executive summary:
Ammonium perchlorate was provided to groups of 24 female rats via drinking water, at dose-levels of 0 (control), 0.01, 0.1, 1 and 30 mg/kg/day before (2 weeks before mating, complete mating) and during gestation (21 days).
At 30 mg/kg/day, there was no maternal toxicity. Pre- and Post-implantation loss indices were higher than in controls but this was not considered to represent relevant resorptions when considering the number of resorptions, implantation sites, live and dead fetuses. There was a minor indication of delayed ossification (fewer ossification sites) but this effect is minimal, and not adverse: it represents a slight delay in development which is usually reversible. No developmental abnormalities were noted. At 0.01 to 1 mg/kg/day, neither maternal nor embryo-/feto- or developmental toxicities were noted.
An additional 16 Iitters/group were sacrificed on DG 21 for maternal and fetal serum TSH, T3, and T4 levels and thyroid histopathology. General and reproductive toxicology parameters were comparable among the groups with only delays in ossification observed in the 30 mg/kg-day group.
Maternal thyroid weights were increased in the 30.0 mg/kg-day group. Decreased colloid was present in male and female fetal thyroids in the 1.0 and 30.0 mg/kg-day groups. Maternal TSH was increased and T 4 was decreased at all levels, and T 3 was reduced at 30.0 mg/kg-day. Fetal TSH was increased at 1.0 and 30.0 mg/kg-day, T4 was reduced at 30.0 mg/kg-day, and T3 was decreased at all levels.
The maternal no-observable-adverse-effect level (NOAEL) was 1.0 mg/kg-day; exposures of 30.0 mg/kg-day increased absolute and relative maternal thyroid weights and histopathology findings.
The developmental NOAEL was 30.0 mg/kg-day. The colloid depletion in the thyroids and increased TSH and decreased T3 and T4 levels at lower exposures were considered adaptive and not adverse.
No adverse effects on development occurred at levels that did not cause maternal toxicity, therefore ammonium perchlorate is not a selective developmental toxicant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.